Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

40results about How to "Reduce extent" patented technology

Devices, Methods, and Graphical User Interfaces for Manipulating User Interface Objects with Visual and/or Haptic Feedback

A device concurrently displays a background user interface and a first version of a notification associated with a first application. The device detects a first contact at a location that corresponds to the first version of the notification. In response to the detection, and upon a determination that the contact meets application-launching criteria, the device initiates a process to launch the first application. In response to the detecting, and upon a determination that the contact meets notification-expansion criteria, where the notification-expansion criteria require that the characteristic intensity of the contact meet a preview intensity threshold, the device displays a second version of the notification, where the second version of the notification has a size larger than the first version, includes expanded notification content that is not displayed in the first version, and is overlaid on the background user interface.
Owner:APPLE INC

Accessing and displaying information corresponding to past times and future times

The present disclosure relates to techniques accessing and displaying information pertaining to past times and future times. In some embodiments, a device displays a first current-time indicator and a user interface object configured to display information corresponding to a first information source and to the current time. In some embodiments, in response to and in accordance with detecting a rotation of a rotatable input mechanism, the device displays a non-current-time indicator indicating a non-current time, and updates the first user interface object to display information corresponding to the first information source and the non-current time. In some embodiments, the device continues to display an indication of the current time.
Owner:APPLE INC

Method and Apparatus for Controlling a Bodily Function

InactiveUS20090306460A1Improve system performanceOptimum for bladder controlElectrotherapyProsthesisUrethraSphincter
The present invention relates to a method and apparatus for controlling urinary incontinence. An implantable stimulator is utilised to apply stimulation to a sphincter or neosphincter about the urethra, in order to maintain coaptation of the urethra and urinary continence. Feedback is utilised in order to vary the level of stimulation applied to the sphincter in order to enable control over the sphincter. Control may be implemented by a user setting levels, by biofeedback, by a clinician.
Owner:CONTINENCE CONTROL SYST INT

Method for reduced-artifact radiological 3D imaging, medical imaging device and method for creating a therapy plan

The invention relates to a method for reduced-artifact 3D-imaging of an imaging volume comprising an interfering element a patient is positioned in a first and second positions spatially different from each other in an imaging device and a first and second 3D-imagings are performed with the interfering element lying within a first and second radiographic layer. A first and second set of raw data of the imaging volume are provided with the first set having artifact-influenced raw data for the first radiographic layer and the second set having artifact-influenced raw data for the second radiographic layer and non-artifact influenced raw data for the first radiographic layer the reduced-artifact 3D data set is created By combining the raw data sets for calculating the reduced-artifact 3D data set or by calculating a first and second 3D image data sets from the raw data sets and combining the 3D image data sets.
Owner:SIEMENS AG

Purification of fusion proteins

The invention relates generally to methods for purifying a Fc-fusion protein produced in a eukaryotic expression system. More specifically, the invention provides a robust and scalable downstream purification process suitable for use in manufacturing TNFR:Fc for human administration which comprises an optimized Protein A affinity chromatography step and two ion exchange chromatography steps both of which are operated in the bind-and-elute mode.
Owner:MERCK SHARP & DOHME CORP

Accessing and displaying information corresponding to past times and future times

The present disclosure relates to techniques accessing and displaying information pertaining to past times and future times. In some embodiments, a device displays a first current-time indicator and a user interface object configured to display information corresponding to a first information source and to the current time. In some embodiments, in response to and in accordance with detecting a rotation of a rotatable input mechanism, the device displays a non-current-time indicator indicating a non-current time, and updates the first user interface object to display information corresponding to the first information source and the non-current time. In some embodiments, the device continues to display an indication of the current time.
Owner:APPLE INC

Crane Mat Carrier

A user-friendly crane mat carrier is provided for conveniently transporting, storing and supporting crane mats, pads and other items. The economical light weight crane mat assembly can comprise a frame assembly with a main load-supporting bar, crossbars and perimeter bars. The special crane mat carrier can be easily connected to a crane, such as with a drawbar fixture, securing plate and locking plate. A hanger assembly with a suspension bar can be provided to hang the crane mat carrier. A latch mechanism can also be provided to securely lock the crane mat carrier.
Owner:TOTAL SUPPORT

Apparatus and method for fat removal

InactiveUS20110046616A1Facilitate ablationFacilitate a rapid healing of the tissueSurgical instruments for heatingSubcutaneous fatty tissueRadiation pulse
Exemplary embodiments of the present disclosure provide methods and apparatus for heating and removing subcutaneous fatty tissue using radiation. For example, an ablative laser or the like can be configured to generate a small hole in skin tissue that passes through the entire layer of dermal tissue. The hole size can be small, e.g., on less than about 1 mm or 0.5 mm in diameter. Continued application of the radiation can heat and / or vaporize subcutaneous fat proximal to the lower portion of the hole. Expansion of the heated or vaporized fatty tissue can facilitate ejection of the fatty tissue from the formed hole. The energy of a radiation pulse used to form a hole and heat the fatty tissue can be, e.g., greater than about 0.5 J, e.g., between about 0.5 J and about 35 J. The skin tissue can be cooled or partially frozen before forming one or more such holes therein, and a stabilizing film or plate may be adhered to the skin surface to help stabilize the ablated holes.
Owner:THE GENERAL HOSPITAL CORP

Devices and Methods for Adjusting the Provision of Notifications

While an electronic device with a display is in a reduced notification mode, the device receives one or more communications. After receiving the one or more communications, the device detects an alert condition for the reduced notification mode. In response to detecting the alert condition for the reduced notification mode, the device displays a first user interface that includes a first affordance which, when activated, causes deactivation of the reduced notification mode of the electronic device. In response to detecting a first input that activates the first affordance, the device deactivates the reduced notification mode, and displays a second user interface. The second user interface does not display content from any one of the one or more communications. While the second user interface is displayed, in response to detecting a second input, the device displays notifications that include content for at least some of the one or more communications.
Owner:APPLE INC

Method for reducing sidewall etch residue

A method for fabricating a semiconductor device is provided. The method comprising forming a first layer over a substrate and a second layer over the first layer. A patterned masking layer is subsequently provided over the second layer and a patterned second layer with outwardly tapered sidewalls is formed by isotropically etching exposed portions of the second layer. A patterned first layer is the formed by etching the first layer in accordance with the patterned second layer.
Owner:CHARTERED SEMICONDUCTOR MANUFACTURING +1

Energy efficient bushing for a transformer

A bushing for a transformer is provided, the bushing comprising an elongate enclosure body to accommodate a conductor extending along a longitudinal axis, the conductor having a first terminal end a second terminal end, the ends extending from opposite sides of the enclosure body; and a mounting flange fitted to the enclosure body to enable the bushing to be mounted to an enclosure of the transformer. The enclosure body comprises two electrically insulating layers partially surrounding the conductor, a first layer of the insulating layers being substantially provided by a first polymeric material and a second layer of the insulating layers being substantially provided by a second polymeric material, the layers being arranged about the conductor in such a manner that the bushing is substantially cavity-free. In an embodiment, the first layer defines an inner core, with the second layer providing an outer cover which at least partially covers the inner core.
Owner:POWER HV INC

Dragon's blood anti-viral materials and methods

The present invention provides for the administration of compounds, which can be synthesized or can be isolated from a Croton plant species for treating invertebrates or vertebrates, including humans, infected with Poxyiridae or Papillomavirinae. The present invention encompasses methods of using compounds synthesized or isolated from the Croton plant species, singularly or synergistically.
Owner:KONZ PAUL +3

Harness

A harness (1; 33) for supporting a fractured clavicle, the harness comprising a first part (3; 35) that is securable about the waist of a user and extends in use to cover at least a portion of the user's back, and first and second straps (13, 15; 39, 41) secured to that portion of the first part (3, 35) that covers at least a portion of the user's back in use, wherein the first and second straps (13, 15; 39, 41) are capable of being looped over the user's shoulders, under the user's arms and can be secured in position, and at least one of said first and second straps includes a support member (19; 45) that is configured to locate beneath at least part of the fractured clavicle to support and align the component parts of the fractured clavicle whilst the clavicle heals.
Owner:THOMPSON BARBARA

Devices, Methods, and Graphical User Interfaces for Seamless Transition of User Interface Behaviors

An electronic device presents a user interface including an output property that represents a first type of output. The device detects a first input associated with modifying the first type of output via a first behavior model, and changes the output property over time based on the first behavior model and updates the user interface based on the changes in the output property. While updating the user interface, the device detects a change to the user input; and changes the output property over time based on a second behavior model based on: a value of the output property determined based on the first behavior model; and a first derivative of the value of the output property with respect to time determined based on the first behavior model. The device updates the user interface based on the changes in the output property that occur based on the second behavior model.
Owner:APPLE INC

Compositions, devices, systems, kits and methods for the treatment of a skin condition

A multi-component regimen for the treatment of a skin condition including administering at least two components of at least one galenic microbial composition, applying at least one acidic composition, applying at least one mineral salt composition, illuminating an area of the skin and heating an area of the skin. The regimen includes at least one of administering at least one galenic microbial composition and illuminating an area of the skin. Also provided is a galenic microbial composition including bacteria of the phylum Actinobacterium and a dermatologically compatible carrier. Further provided is a wearable cutaneous treatment device for the therapeutic illumination of mammalian skin when activated, to project light outwards from the inner surface to illuminate at least a portion the area of skin.
Owner:CLEARSKIN LTD

Chlorotoxin polypeptides and conjugates and uses thereof

Reduced lysine chlorotoxin polypeptides that may be used to generate single species conjugates of chlorotoxin. Conjugates comprising such chlorotoxin polypeptides and pharmaceutical compositions thereof. Methods of using such compositions and / or conjugates.
Owner:EISAI INC

Methods and compositions for treating melanoma

The present invention relates to a method and composition for treating melanoma, aggressive / invasive melanoma, metastatic melanoma or melanoma resistant. More particularly, inventors have shown that high expression of PTX3 correlates with melanoma invasiveness and with a poorer survival rate in metastatic melanoma patients. PTX3 knockdown inhibited melanoma cell migration, invasion, lung metastasis, and NFκB signaling pathway. An addition of melanoma-derived or recombinant PTX3, or overexpression of PTX3 enhanced motility of low migratory cells. Finally, they found that TLR4 and MYD88 knockdown or targeting inhibited PTX3-induced melanoma cell migration, suggesting that PTX3 functions through a TLR4 / NFκB-dependent pathway. Accordingly, the invention relates to a method for predicting the survival time of a subject suffering from melanoma, aggressive / invasive melanoma, metastatic melanoma or melanoma resistant by quantifying the expression level of PTX3 in a biological sample and to a method of treating melanoma, aggressive / invasive melanoma, metastatic melanoma or melanoma resistant by using the inhibitors of PTX3.
Owner:INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM) +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products